Please try another search
Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine for the prevention of invasive pneumococcal disease. The company also develops VAX-31 to protect against emerging strains and to help address antibiotic resistance; VAX-A1, a novel conjugate vaccine candidate to prevent disease caused by Group A Streptococcus; VAX-PG, a novel protein vaccine candidate targeting keystone pathogen responsible for periodontitis; and VAX-GI to prevent Shigella, a bacterial illness. The company was formerly known as SutroVax, Inc. and changed its name to Vaxcyte, Inc. in May 2020. Vaxcyte, Inc. was incorporated in 2013 and is headquartered in San Carlos, California.
Name | Age | Since | Title |
---|---|---|---|
Grant E. Pickering | 54 | 2013 | Co-Founder, CEO & Director |
Carlos V. Paya | 63 | 2021 | Independent Chairman of the Board |
Anthony W. Ford-Hutchinson | - | - | Member of Scientific Advisory Board |
Thomas P. Monath | 81 | - | Member of Scientific Advisory Board |
Jeffrey Almond | - | 2017 | Member of Scientific Advisory Board |
Teri Loxam | 50 | 2021 | Independent Director |
Annie Seibold Drapeau | 55 | 2021 | Independent Director |
Halley E. Gilbert | 52 | 2020 | Independent Director |
Heath Lukatch | 55 | 2018 | Independent Director |
Emmanuel Hanon | - | - | Member of Scientific Advisory Board |
Emmanuel Walter | - | - | Member of Scientific Advisory Board |
William Hausdorff | - | - | Member of Scientific Advisory Board |
Jacks Lee | 60 | 2023 | Independent Director |
K. Peter Hirth | 72 | 2016 | Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review